PuSH - Publication Server of Helmholtz Zentrum München

Braun, A. ; Engel, T. ; Aguilar-Pimentel, J.A. ; Zimmer, A.* ; Jakob, T.* ; Behrendt, H. ; Mempel, M.

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors.

Immunobiology 216, 466-476 (2011)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
The endocannabinoid system (ECS) consists of two cannabinoid (CB) receptors, namely CB(1) and CB(2) receptor, and their endogenous (endocannabinoids) and exogenous (cannabinoids, e.g. delta-9-tetrahydrocannabinol (THC)) ligands which bind to these receptors. Based on studies suggesting a role of THC and the ECS in inflammation, the objective of this study was to examine their involvement in type I hypersensitivity using a murine model of allergic airway inflammation. THC treatment of C57BL/6 wildtype mice dramatically reduced airway inflammation as determined by significantly reduced total cell counts in bronchoalveolar lavage (BAL). These effects were greatest when mice were treated during both, the sensitization and the challenge phase. Furthermore, systemic immune responses were significantly suppressed in mice which received THC during sensitization phase. To investigate a role of CB(1/2) receptors in this setting, we used pharmacological blockade of CB(1) and/or CB(2) receptors by the selective antagonists and moreover CB(1)/CB(2) receptor double-knockout mice (CB(1)(-/-)/CB(2)(-/-)) and found neither significant changes in the cell patterns in BAL nor in immunoglobulin levels as compared to wildtype mice. Our results indicate that the activation of the ECS by applying the agonist THC is involved in the development of type I allergies. However, CB(1)/CB(2) receptor-independent signalling seems likely in the observed results.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Asthma; Cannabinoid receptors; Endocannabinoid system; THC; Inflammation
ISSN (print) / ISBN 0171-2985
e-ISSN 1878-3279
Journal Immunobiology : Experimental and Clinical
Quellenangaben Volume: 216, Issue: 4, Pages: 466-476 Article Number: , Supplement: ,
Publisher Urban & Fischer
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) CCG Environmental Dermatology and Allergology (ILBD-KAU)
Institute of Epidemiology (EPI)